| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |